Daily Ards Research Analysis
Today’s top papers span mechanistic, interventional, and physiologic insights across acute lung injury and respiratory distress. A preclinical study identifies neutrophil extracellular traps as drivers of inflammation and coagulopathy in primary blast lung injury with reversal by DNase I, an RCT protocol tests a low-cost knee-to-chest flexion maneuver to reduce neonatal respiratory distress after elective cesarean, and a mini-review clarifies how elevated alveolar surface tension promotes pulmon
Summary
Today’s top papers span mechanistic, interventional, and physiologic insights across acute lung injury and respiratory distress. A preclinical study identifies neutrophil extracellular traps as drivers of inflammation and coagulopathy in primary blast lung injury with reversal by DNase I, an RCT protocol tests a low-cost knee-to-chest flexion maneuver to reduce neonatal respiratory distress after elective cesarean, and a mini-review clarifies how elevated alveolar surface tension promotes pulmonary edema independent of permeability changes.
Research Themes
- NETs as mechanistic drivers and therapeutic targets in acute lung injury
- Low-cost perinatal interventions to prevent neonatal respiratory distress
- Surfactant-mediated surface tension and lung fluid balance
Selected Articles
1. Neutrophil extracellular traps mediate inflammation and coagulation dysregulation in primary blast lung injury.
In a rat PBLI model, blast exposure increased NETs, inflammatory cytokines, coagulation factors, and endothelial injury markers; PMVEC co-cultured with PBLI neutrophils recapitulated these changes. DNase I reduced NET-mediated tissue damage and endothelial dysfunction, identifying NETs as mechanistic drivers and potential therapeutic targets in PBLI.
Impact: This study provides mechanistic evidence that NETs drive inflammation and coagulopathy in blast lung injury and demonstrates pharmacologic reversibility with DNase I.
Clinical Implications: Anti-NET strategies (e.g., DNase I) merit evaluation in trauma-related lung injury and could inform adjunctive therapies for acute lung injury phenotypes characterized by coagulopathy.
Key Findings
- Blast exposure in rats increased lung structural damage, inflammatory cytokines, coagulation-related factors, endothelial injury markers, and NETs release versus controls.
- PMVEC co-cultured with neutrophils from PBLI rats showed upregulation of inflammatory, coagulation, and endothelial injury markers.
- DNase I administration reversed NET-mediated lung tissue damage and PMVEC dysfunction.
- Findings implicate NETs as key mediators of PBLI-associated inflammation and coagulopathy.
Methodological Strengths
- Integrated in vivo rat model with in vitro PMVEC co-culture to triangulate mechanism
- Mechanistic intervention using DNase I demonstrated reversibility and causality
Limitations
- Preclinical animal study without human validation or clinical outcomes
- Model limited to blast injury; generalizability to other ALI/ARDS etiologies is uncertain
Future Directions: Evaluate DNase I or other anti-NET strategies in large-animal models and trauma cohorts; define optimal timing/dose and interactions with coagulation pathways.
Primary blast lung injury (PBLI) manifests as respiratory distress and hemoptysis syndrome resulting from exposure to blast waves, yet its pathogenesis remains incompletely understood, leading to a dearth of effective treatment options. Neutrophil extracellular traps (NETs) may play important roles in acute lung injury. However, the role of NETs in PBLI was unclear. Therefore, the objective of the present study was to investigate the role of NETs in PBLI. Our study found that, compared to the Con group, blast wave induced the destruction of lung tissue structure, the increase of lung inflammatory factors, coagulation-related factors, and endothelial injury markers, as well as the release of NETs. Further research showed that the levels of inflammatory factors, coagulation-related factors, and endothelial injury markers of pulmonary microvascular endothelial cells (PMVEC) were up-regulated after co-culturing with neutrophils extracted from the blood of PBLI rats, compared to the Con group. The damaging effect of NETs on the lung tissue of rats and PMVEC was reversed after DNase I was applied. Our work revealed that blast exposure induces lung tissue inflammation and coagulation disorders in PBLI rats by mediating PMVEC dysfunction, thereby accelerating the development of PBLI. Moreover, NETs are the key factors causing inflammation and coagulation disorders of PBLI, and the elimination of NETs may become a new target for PBLI therapy.
2. The effectiveness of knee-chest-flexion maneuver in reducing respiratory distress in elective cesarean section newborns: protocol for a randomized controlled trial.
This registered two-center RCT will randomize 521 elective CS newborns to knee-to-chest flexion versus standard care, with 24-hour follow-up for respiratory distress. The maneuver aims to mimic labor-associated fluid clearance by transiently increasing transthoracic and transpulmonary pressures to expel lung liquid.
Impact: If effective, a simple, low-cost, and scalable maneuver could reduce CS-associated neonatal respiratory morbidity globally, including in low-resource settings.
Clinical Implications: Adoption of KCF in delivery rooms could reduce early neonatal respiratory distress and NICU admissions after elective CS without additional equipment.
Key Findings
- Randomized, two-arm trial of 521 elective CS newborns comparing knee-to-chest flexion versus standard care with 24-hour follow-up.
- Primary outcome is respiratory distress occurrence; secondary outcome is Neonatal Care Unit admission.
- Rationale: absence of labor reduces fetal flexion and lung liquid clearance; prior feasibility and safety of KCF have been demonstrated.
Methodological Strengths
- Randomized controlled design with adequate sample size (n=521) and trial registration
- Clear primary and secondary outcomes with pragmatic delivery-room implementation
Limitations
- Protocol paper with no outcome data yet; effectiveness and safety remain to be demonstrated
- Generalizability may be limited to elective CS settings and trained personnel; standardization of the maneuver may vary
Future Directions: If effective, evaluate scale-up, training requirements, timing, and physiologic monitoring; compare with other noninvasive measures to enhance lung fluid clearance.
BACKGROUND: Cesarean section (CS) birth is a risk factor for respiratory distress (RD) in term and near-term infants, which has been steadily increasing globally. The absence of labor has been linked to RD resulting from planned CS births. Uterine contractions contribute to the dorsiflexed position of the fetus which increases abdominal and trans-pulmonary pressure resulting in lung liquid loss via nose and mouth. We recently demonstrated the feasibility and safety of applying Knee-to-Chest Flexion (KCF), where the newborn was placed in a flexed "fetal" position, leading to lung liquid expulsion. In this trial, the effectiveness of the KCF maneuver in reducing RD in infants delivered by planned CS will be examined. METHODS: This will be a randomized controlled two-arm trial in which 521 infants born by elective CS at 37-42 weeks gestational age will be randomized, in 1:1 ratio, to receive either a KCF maneuver or standard care, before being followed up for at least 24 h. The study will be conducted at Kilimanjaro Christian Medical Centre hospital and Mawenzi Regional Referral hospital in Tanzania. Consent will be sought from mothers scheduled for elective CS prior to randomization. The primary outcome is the occurrence of respiratory distress. Secondary outcome is admission to Neonatal Care Unit. DISCUSSION: This trial investigates KCF maneuver as an intervention to facilitate lung liquid clearance in newborns born by planned CS. It is anticipated to produce evidence of KCF as a highly cost effective innovation that will improve neonatal outcomes in clinical settings. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT06270823.
3. The role of pulmonary surfactant on lung fluid balance.
Loss of surfactant elevates alveolar surface tension, increasing perialveolar subatmospheric pressure and microvascular filtration, thereby promoting pulmonary edema without increasing capillary permeability. Experimental correlations and Starling-based modeling support surface tension as a key determinant of lung fluid balance.
Impact: By clarifying a non-permeability mechanism for edema, this work informs ventilatory strategies and surfactant-targeted therapies in ALI/ARDS and other edematous lung states.
Clinical Implications: Clinical management should prioritize maintaining low alveolar surface tension (e.g., avoid surfactant deactivation, consider surfactant therapy) and ventilatory settings that minimize end-expiratory surface tension to limit edema.
Key Findings
- Increased end-expiratory alveolar surface tension elevates perialveolar subatmospheric pressure and microvascular filtration.
- Higher surface tension (γ) correlates with increased pulmonary extravascular water volume (PEWV), with reported values linking γ to PEWV.
- Elevated γ did not increase capillary permeability, supporting an interstitial hydrostatic pressure mechanism.
- Starling equation-based computational modeling demonstrates the impact of elevated γ on lung fluid balance.
Methodological Strengths
- Synthesis of experimental data with quantitative modeling grounded in Starling’s law
- Physiologically coherent framework linking surface tension to edema formation
Limitations
- Mini-review format; not a systematic review with formal bias assessment
- Limited direct clinical outcome data linking interventions on surface tension to patient endpoints
Future Directions: Prospective clinical studies correlating measures of alveolar surface tension with lung water and outcomes; trials of surfactant-preserving strategies in ALI/ARDS.
Karl von Neegaard's classic publication, in 1929, first identified the physiological function of pulmonary surfactant on alveolar mechanics. Dr. John Allen Clements brought this work to the clinic in the 1960s, culminating in the development of surfactant replacement therapy for infant respiratory distress syndrome (RDS). In this mini-review, we discuss pulmonary surfactants' role in maintaining lung fluid balance, which is essential in preventing pulmonary edema. Alveolar surface tension (γ) is transmitted into the perialveolar space surrounding pulmonary capillaries and corner vessels. Increasing surface tension at end expiration would increase alveolar recoil pressure and decrease alveolar radius, thus causing more subatmospheric pressure in the perialveolar space, generating an increased gradient for microvascular filtration. Studies have demonstrated a positive correlation between increased pulmonary extravascular water volume (PEWV) and high γ (γ = 8.3 ± 1.7 dyn/cm; PEWV = 3.4 ± 0.2 mL/g vs. γ = 23.2 ± 0.4 dyn/cm; PEWV = 6.1 ± 1.0 mL/g dry lung). A subsequent study demonstrated that the high γ did not increase capillary permeability, supporting the mechanism of high γ-induced pulmonary edema as a decrease in interstitial hydrostatic pressure. Computational modeling, as presented in our previous publications based on the Starling equation of fluid flux, identifies the impact of elevated alveolar surface tension on lung fluid balance. Loss of surfactant function favors fluid moving from the capillary across the endothelium into the perialveolar space and across the epithelium into the alveoli. We conclude that elevated alveolar surface tension plays a pivotal role in lung fluid balance and, if sufficiently elevated, can cause pulmonary edema even with normal capillary permeability.